Cancer Chemoprevention by Polyphenols and Their Potential Application as Nanomedicine

REFERENCES

• Howe , H L , Wingo , P A , Thun , M J , Ries , LA , Rosenberg , HM and Fiegal , EG . 2001 . Annual report to the nation on the status of cancer (1972–1998), featuring cancers with recent increasing trend . J Natl Cancer Inst. , 93 : 824 – 842 .
   PubMed Web of Science ®Google Scholar
• Jemal , A , Thomas , A , Murray , T N and Thun , M . 2002 . Cancer statistics, 2002 . Cancer J Clin. , 52 : 23 – 47 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B and Shishodia , S . 2006 . Molecular targets of dietary agents for prevention and therapy of cancer . Biochem Pharmacol , 71 : 1397 – 1421 .
   PubMed Web of Science ®Google Scholar
• Jemal , A , Siegel , R , Ward , E , Murray , T , Xu , J and Thun , M J . 2007 . Cancer statistics, 2007 . Cancer J Clin. , 57 : 43 – 66 .
   PubMed Web of Science ®Google Scholar
• Nowell , P C . 1986 . Mechanisms of tumor progression . Cancer Res , 46 : 2203 – 2207 .
   PubMed Web of Science ®Google Scholar
• Sporn , M B and Suh , N . 2002 . Chemoprevention: an essential approach to controlling cancer . Nat Rev Cancer , 2 : 537 – 543 .
   PubMed Web of Science ®Google Scholar
• Sporn , M B . 1991 . Carcinogenesis and cancer: different perspectives on the same disease . Cancer Res , 51 : 6215 – 6218 .
   PubMed Web of Science ®Google Scholar
• Khan , N and Mukhtar , H . 2008 . Multitargeted therapy of cancer by green tea polyphenols . Cancer Lett , 269 : 269 – 280 .
   PubMed Web of Science ®Google Scholar
• Wattenberg , W L . 1985 . Chemoprevention of cancer . Cancer Res , 45 : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Khan , N and Mukhtar , H . 2010 . Cancer chemoprevention . Comprehensive Toxicol. , 14 : 417 – 431 .
   Google Scholar
• Bode , A M and Dong , Z . 2004 . Targeting signal transduction pathways by chemopreventive agents . Mutat Res. , 555 : 33 – 51 .
   PubMed Web of Science ®Google Scholar
• Stevenson , D E and Hurst , R D . 2007 . Polyphenolic phytochemicals—just antioxidants or much more? . Cell Mol Life Sci , 64 : 2900 – 2916 .
   PubMed Web of Science ®Google Scholar
• Di Domenico , F , Foppoli , C , Coccia , R and Perluigi , M . 2011 . Antioxidants in cervical cancer: chemopreventive and chemotherapeutic effects of polyphenols . Biochim Biophys Acta , doi:10.1016/j.bbadis.2011.10.005
   Google Scholar
• Shukla , S and Gupta , S . 2010 . “ Apigenin and cancer chemoprevention ” . In Bioactive foods in promoting health: fruit and vegetables Edited by: Watson , R R and Pree , V R . 663 – 689 . Elsevier: Netherlands
   Google Scholar
• Khan , N and Mukhtar , H . 2010 . Cancer and metastasis: prevention and treatment by green tea . Cancer Metastasis Rev , 29 : 435 – 445 .
   PubMed Web of Science ®Google Scholar
• Fresco , P , Borges , F , Diniz , C and Marques , M P . 2006 . New insights into the anticancer properties of polyphenols . Med Res Rev , 26 : 747 – 766 .
   PubMed Web of Science ®Google Scholar
• Duthie , S J . 2007 . Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process . Mol Nutr Food Res , 51 : 665 – 674 .
   PubMed Web of Science ®Google Scholar
• Wahle , K WJ , Rotondo , D , Brown , I and Heys , S D . 2009 . “ Plant phenolics in the prevention and treatment of cancer ” . In Bio-farms for nutraceuticals: functional food and safety control by biosensors , Edited by: Giardi , M T , Rea , G and Berra , B . Landes Bioscience and Springer Science: New York .
   Google Scholar
• Tyagi , S , Singh , G , Sharma , A and Aggarwal , G . 2010 . Phytochemicals as candidate therapeutics: an overview . Int J Pharmac Sci Rev Res , 3 ( 1 ) : 53 – 55 .
   Google Scholar
• Perron , N R and Brumaghim , J L . 2009 . A review of the antioxidant mechanisms of polyphenol compounds related to iron binding . Cell Biochem Biophys. , 53 : 75 – 100 .
   PubMed Web of Science ®Google Scholar
• Hu , M-L. 2011 . Dietary polyphenols as antioxidants and anticancer agents: more questions than answers . Chang Gung Med J. , 34 : 449 – 460 .
   PubMedGoogle Scholar
• Chen , H , Yao , K , Nadas , J , Bode , A M , Malakhova , M Oi , N . 2012 . Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods . PLoS ONE. , 7 ( 5 ) : e38261 doi:10.1371/journal.pone.0038261
   PubMedGoogle Scholar
• Chahar , MK , Sharma , N , Dobhal , M P and Joshi , Y C . 2011 . Flavonoids: a versatile source of anticancer drugs . Pharmacogn Rev , 5 ( 9 ) : 1 – 12 .
   PubMedGoogle Scholar
• Kanadaswami , C , Lee , L-T , Lee , P-PH , Hwang , J J , Ke , F C , Huang , Y T and Lee , M-T . 2005 . The antitumor activities of flavonoids . In vivo , 19 : 895 – 910 .
   PubMed Web of Science ®Google Scholar
• Ghiringhelli , F , Rébé , C , Hichami , A and Delmas , D . 2012 . Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents . Anticancer Agents Med Chem , 12 ( 8 ) : 852 – 873 .
   PubMed Web of Science ®Google Scholar
• Mohan , A , Narayanan , S , Sethuraman , S and Krishnan , U M . 2013 . Combinations of plant polyphenols and anticancer molecules: a novel treatment strategy for cancer chemotherapy . Anticancer Agents Med Chem , 13 ( 2 ) : 281 – 295 .
   PubMed Web of Science ®Google Scholar
• Spatafora , C and Tringali , C . 2012 . Natural-derived polyphenols as potential anticancer agents . Anticancer Agents Med Chem , 12 ( 8 ) : 902 – 918 .
   PubMed Web of Science ®Google Scholar
• Bode , A M and Dong , Z . 2006 . Molecular and cellular targets . Mol Carcinog. , 45 ( 6 ) : 422 – 430 .
   PubMed Web of Science ®Google Scholar
• Morley , N , Clifford , T , Salter , L , Campbell , S , Gould , D and Curnow , A . 2005 . The green tea polyphenol (−)-epigallocatechin gallate and green tea can protect human cellular DNA from ultraviolet and visible radiation-induced damage . Photodermatol Photoimmunol Photomed. , 21 : 15 – 22 .
   PubMed Web of Science ®Google Scholar
• Umemura , T , Kai , S , Hasegawa , R , Kanki , K , Kitamura , Y Nishikawa , A . 2003 . Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamineinduced hepato- and cholangiocarcinogenesis in mice by green tea infusion . Carcinogenesis. , 24 : 1105 – 1109 .
   PubMed Web of Science ®Google Scholar
• Ioannides , C and Yoxall , V . 2003 . Antimutagenic activity of tea: role of polyphenols . Curr Opin Clin Nutr Metab Care , 6 ( 6 ) : 649 – 656 .
   PubMed Web of Science ®Google Scholar
• Yamagishi , M , Natsume , M , Nagaki , A , Adachi , T , Osakabe , N , Takizawa , T , Kumon , H and Osawa , T . 2000 . Antimutagenic activity of cacao: inhibitory effect of cacao liquor polyphenols on the mutagenic action of heterocyclic amines . J Agric Food Chem , 48 ( 10 ) : 5074 – 5078 .
   PubMed Web of Science ®Google Scholar
• Santhosh , KT , Swarnam , J and Ramadasan , K . 2005 . Potent suppressive effect of green tea polyphenols on tobacco-induced mutagenicity . Phytomedicine , 12 ( 3 ) : 216 – 220 .
   PubMedGoogle Scholar
• Krishnan , R and Maru , G B . 2005 . Inhibitory effect(s) of polymeric black tea polyphenols on the formation of B(a)P-derived DNA adducts in mouse skin . J Environ Pathol Toxicol Oncol , 24 ( 2 ) : 79 – 90 .
   PubMedGoogle Scholar
• Moon , YJ , Wang , X and Morris , M E . 2006 . Dietary flavonoids: effects on xenobiotic and carcinogen metabolism . Toxicol In Vitro , 20 ( 2 ) : 187 – 210 .
   PubMed Web of Science ®Google Scholar
• Johnson , M K and Loo , G . 2000 . Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA . Mutat Res. , 459 : 211 – 218 .
   PubMed Web of Science ®Google Scholar
• Heijnen , C G , Haenen , G R , van Acker , F A , van der Vijgh , W J and Bast , A . 2001 . Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups . Toxicol In Vitro. , 15 : 3 – 6 .
   PubMed Web of Science ®Google Scholar
• Rajendran , P , Ekambaram , G and Sakthisekaran , D . 2008 . Cytoprotective effect of mangiferin on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice . Basic Clin Pharmacol Toxicol. , 103 : 137 – 142 .
   PubMed Web of Science ®Google Scholar
• Lee , D E , Shin , B J , Hur , H J , Kim , J H , Kim , J Kang , N J . 2010 . Quercetin, the active phenolic component in kiwifruit, prevents hydrogen peroxide-induced inhibition of gap-junction intercellular communication . Br J Nutr. , 104 : 164 – 170 .
   PubMed Web of Science ®Google Scholar
• Fresco , P , Borges , F , Diniz , C and Marques , M P . 2006 . New insights into the anticancer properties of polyphenols . Med Res Rev , 26 : 747 – 766 .
   PubMed Web of Science ®Google Scholar
• Le Corre , L , Chalabi , N , Delort , L , Bignon , Y-J and Bernard-Gallon , DJ . 2005 . Resveratrol and breast cancer chemoprevention: molecular mechanisms . Mol Nutr Food Res , 49 : 462 – 471 .
   PubMed Web of Science ®Google Scholar
• Plaumann , B , Fritsche , M , Rimpler , H , Brandner , G and Hess , R D . 1996 . Flavonoids activate wild-type p53 . Oncogene , 13 : 1605 – 1614 .
   PubMed Web of Science ®Google Scholar
• Ren , W , Qiao , Z , Wang , H , Zhu , L and Zhang , L . 2003 . Flavonoids: promising anticancer agents . Med Res Rev. , 23 ( 4 ) : 519 – 534 .
   PubMed Web of Science ®Google Scholar
• Gerritsen , M E . 1998 . Flavonoids: inhibitors of cytokine induced gene expression . Adv Exp Med Biol. , 439 : 183 – 190 .
   PubMedGoogle Scholar
• Amado , N G , Fonseca , B F , Cerqueira , D M , Neto , V M and Abreu , J G . 2011 . Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer . Life Sci , 89 : 545 – 554 .
   PubMed Web of Science ®Google Scholar
• Chen , C , Zhou , J and Ji , C . 2010 . Quercetin: a potential drug to reverse multidrug resistance . Life Sci. , 87 ( 11–12 ) : 333 – 338 .
   PubMed Web of Science ®Google Scholar
• Lugli , E , Ferraresi , R , Roat , E , Troiano , L , Pinti , M Nasi , M . 2009 . Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells . Leukem Res. , 33 ( 1 ) : 140 – 150 .
   PubMedGoogle Scholar
• Amado , N G , Cerqueira , D M , Menezes , F S , da Silva , J F , Neto , V M and Abreu , J G . 2009 . Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes β-catenin cellular localization . Anticancer Drugs , 20 ( 7 ) : 543 – 552 .
   PubMed Web of Science ®Google Scholar
• Russo , M , Nigro , P , Rosiello , R , D’Arienzo , R and Russo , G L . 2007 . Quercetin enhances CD95- and TRAIL-induced apoptosis in leukemia cell lines . Leukemia. , 21 ( 5 ) : 130 – 1133 .
   Google Scholar
• Kalra , N , Seth , K , Prasad , S , Singh , M , Pant , A B and Shukla , Y . 2007 . Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways . Life Sci. , 80 ( 23 ) : 2137 – 2146 .
   PubMedGoogle Scholar
• Gates , M A , Vitonis , A F , Tworoger , S S , Rosner , B , Titus-Ernstoff , L Hankinson , S E . 2009 . Flavonoid intake and ovarian cancer risk in a population-based case-control study . Int J Cancer. , 124 ( 8 ) : 1918 – 1925 .
   PubMed Web of Science ®Google Scholar
• Cappelletti , V , Miodini , P , Di Fronzo , G and Daidone , M G . 2006 . Modulation of estrogen receptor-β isoforms by phytoestrogens in breast cancer cells . Int J Oncol. , 28 ( 5 ) : 1185 – 1191 .
   PubMedGoogle Scholar
• Mukherjee , S , Acharya , B R , Bhattacharyya , B and Chakrabarti , G . 2010 . Genistein arrests cell cycle progression of A549 cells at the G(2)/M phase and depolymerizes interphase microtubules through binding to a unique site of tubulin . Biochemistry. , 49 ( 8 ) : 1702 – 1712 .
   PubMed Web of Science ®Google Scholar
• Kim , H , Lee , M J , Kim , J E , Park , S D , Moon , H I and Park , W H . 2010 . Genistein suppresses tumor necrosis factor-alpha-induced proliferation via the apoptotic signaling pathway in human aortic smooth muscle cells . J Agric Food Chem. , 58 ( 3 ) : 2015 – 2019 .
   PubMedGoogle Scholar
• Kim , H , Park , J S , Seo , M S , Jung , J W , Lee , Y S and Kang , K S . 2010 . Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/β-catenin signalling or lipolysis . Cell Prolif. , 43 ( 6 ) : 594 – 605 .
   PubMed Web of Science ®Google Scholar
• Pavese , J M , Farmer , R L and Bergan , R C . 2010 . Inhibition of cancer cell invasion and metastasis by genistein . Cancer Metastasis Rev. , 29 ( 3 ) : 465 – 482 .
   PubMed Web of Science ®Google Scholar
• Halliwell , B . 2008 . Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? . Arch Biochem Biophys , 476 ( 2 ) : 107 – 112 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Afaq , F and Mukhtar , H . 2001 . Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells . Biochem Biophy Res Comm , 287 : 914 – 920 .
   PubMed Web of Science ®Google Scholar
• Wei , H , Tye , L , Bresnick , E and Birt , D F . 1990 . Inhibitory effect of apigenin, a plant flavonoid, on epi- dermal ornithine decarboxylase and skin tumor promotion in mice . Cancer Res , 50 : 499 – 502 .
   PubMed Web of Science ®Google Scholar
• Van , D R , Xue , Y , Knudson , A and Pelling , J C . 2003 . The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines . J Nutr , 133 : 3800S – 3804S .
   PubMedGoogle Scholar
• Wang , I K , Lin-Shiau , S Y and Lin , J K . 1999 . Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells . Eur J Cancer , 35 : 1517 – 1525 .
   PubMed Web of Science ®Google Scholar
• Iwashita , K , Kobori , M , Yamaki , K and Tsushida , T . 2000 . Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells . Biosci Biotech Biochem , 64 : 1813 – 1820 .
   PubMed Web of Science ®Google Scholar
• Shukla , S and Gupta , S . 2007 . Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells . Cell Cycle , 6 : 1102 – 1114 .
   PubMed Web of Science ®Google Scholar
• Lepley , D M and Pelling , J C . 1997 . Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin . Mol Carcinogen. , 19 : 74 – 82 .
   PubMed Web of Science ®Google Scholar
• Elangovan , V , Sekar , N and Govindasamy , S . 1994 . Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthreneinduced tumorigenesis . Cancer Lett , 87 : 107 – 113 .
   PubMed Web of Science ®Google Scholar
• Manju , V and Nalini , N . 2005 . Chemopreventive potential of luteolin during colon carcinogenesis induced by 1,2-dimethylhydrazine . Ital J Biochem , 54 : 268 – 275 .
   PubMedGoogle Scholar
• Manju , V and Nalini , N . 2007 . Protective role of luteolin in 1,2- dimethylhydrazine induced experimental colon carcinogenesis . Cell Biochem Funct , 25 : 189 – 194 .
   PubMed Web of Science ®Google Scholar
• López-Lázaro , M . 2009 . Distribution and biological activities of the flavonoid luteolin . Mini-Rev Med Chem , 9 : 31 – 59 .
   PubMed Web of Science ®Google Scholar
• Colomer , R and Menendez , J A . 2006 . Mediterranean diet, olive oil and cancer . Clin Transl Oncol , 8 : 15 – 21 .
   PubMedGoogle Scholar
• Wahle , K WJ , Caruso , D , Ochoa , J and Quiles , JL . 2004 . Olive oil and modulation of cell signaling in disease prevention . Lipids , 39 : 1223 – 1231 .
   PubMed Web of Science ®Google Scholar
• Way , T D , Kao , M C and Lin , J K . 2004 . Apigenein induces apoptosis through proteosomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphoinositol 3-kinase/Akt-dependent pathway . J Biol Chem , 279 ( 6 ) : 4479 – 4489 .
   PubMedGoogle Scholar
• Chung , T W , Moon , S K , Chang , Y C , Ko , J H , Lee , Y C , Cho , G , Kim , S H , Kim , G J and Kim , C H . 2004 . Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism . FASEB J. , 14 : 1670 – 1681 .
   Google Scholar
• Okutan , H , Ozcelikb , N , Yilmazb , H R and Uzb , E . 2005 . Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart . Clin Biochem. , 38 : 191 – 196 .
   PubMed Web of Science ®Google Scholar
• Yamada , Y , Yasui , H and Sakurai , H . 2006 . Suppressive effect of caffeic acid and its derivatives on the generation of UVA-induced reactive oxygen species in the skin of hairless mice and pharmacokinetic analysis on organ distribution of caffeic acid in ddY mice . Photochem Photobiol. , 82 : 1668 – 1676 .
   PubMedGoogle Scholar
• Edderkaoui , M , Odinokova , I , Ohno , I , Gukovsky , I , Go , V L , Pandol , S J and Gukovskaya , A S . 2008 . Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells . World J Gastroenterol. , 14 : 3672 – 3680 .
   PubMed Web of Science ®Google Scholar
• Hagiwara , Y , Kasukabe , T , Kaneko , Y , Niitsu , N and Okabe-Kado , J . 2010 . Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells . Int J Hematol. , 92 : 136 – 143 .
   PubMed Web of Science ®Google Scholar
• Mejia-Meza , E I , Yanez , J A , Remsberg , C M , Takemoto , J K , Davies , N M , Rasco , B and Clary , C . 2010 . Effect of dehydration on raspberries: polyphenol and anthocyanin retention, antioxidant capacity, and antiadipogenic activity . J Food Sci. , 75 : 5 – 12 .
   PubMed Web of Science ®Google Scholar
• Rogerio , A P , Fontanari , C , Borducchi , E , Keller , A C , Russo , M , Soares , E G , Albuquerque , D A and Faccioli , L H . 2008 . Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma . Eur J Pharmacol. , 580 : 262 – 270 .
   PubMed Web of Science ®Google Scholar
• Xu , Y M , Deng , J Z , Ma , J , Chen , S N , Marshall , R , Jones , S H , Johnson , R K and Hecht , S M . 2003 . DNA damaging activity of ellagic acid derivatives . Bioorg Med Chem. , 11 : 1593 – 1596 .
   PubMedGoogle Scholar
• Umesalma , S and Sudhandiran , G . 2011 . Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway . Eur J Pharmacol , 660 : 249 – 258 .
   PubMed Web of Science ®Google Scholar
• Nandakumar , V , Singh , T and Katiyar , S K . 2008 . Multi-targeted prevention and therapy of cancer by proanthocyanidins . Cancer Lett , 269 : 378 – 387 .
   PubMed Web of Science ®Google Scholar
• Sandhar , H K , Kumar , B , Prasher , S , Tiwari , P , Salhan , M and Sharma , P . 2011 . A review of phytochemistry and pharmacology of flavonoids . Int Pharm Sci , 1 ( 1 ) : 25 – 41 .
   Google Scholar
• Marchand , L . 2002 . Cancer preventive effects of flavonoids—a review . Biomed Pharmacother , 56 : 296 – 301 .
   PubMed Web of Science ®Google Scholar
• Brusselmans , K , de Schrijver , E , Heyns , W , Verhoeven , G and Swinnen , J . 2003 . Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells . Int J Cancer. , 106 : 856 – 862 .
   PubMed Web of Science ®Google Scholar
• Horie , N , Hirabayashi , N , Takahashi , Y , Miyauchi , Y , Taguchi , H and Takeishi , K . 2005 . Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells . Biol Pharm Bull. , 28 : 574 – 579 .
   PubMed Web of Science ®Google Scholar
• Chen , C , Shen , G , Hebbar , V , Hu , R , Owuor , E and Kong , A . 2003 . Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells . Carcinogen. , 24 : 1369 – 1378 .
   PubMed Web of Science ®Google Scholar
• Wang , H , Bian , S and Yang , C S . 2011 . Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α . Carcinogen , doi:10.1093/carcin/bgr218
   Google Scholar
• Khan , N , Afaq , F and Mukhtar , H . 2007 . Cancer chemoprevention through dietary antioxidants: progress and promise . Antioxid Redox Signal. , 10 : 475 – 510 .
   Google Scholar
• Punathil , T , Tollefsbol , T O and Katiyar , S K . 2008 . EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclise . Biochem Biophys Res Commun. , 375 ( 1 ) : 162 – 167 .
   PubMedGoogle Scholar
• Sah , JF , Balasubramanian , S , Eckert , RL and Rorke , E A . 2004 . Epigallocatechin-3-gallatem inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases . J Biol Chem. , 279 : 12755 – 12762 .
   PubMed Web of Science ®Google Scholar
• Khan , N , Afaq , F , Saleem , M , Ahmad , N and Mukhtar , H . 2006 . Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate . Cancer Res. , 66 : 2500 – 2505 .
   PubMed Web of Science ®Google Scholar
• Surh , YJ and Na , H K . 2008 . NF-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals . Genes Nutr. , 2 ( 4 ) : 313 – 317 .
   PubMedGoogle Scholar
• Kundu , J K and Suhr , Y J . 2004 . Molecular basis of chemoprevention by resveratrol: NF-kB and AP-1 as potential targets . Mutat Res. , 555 : 65 – 80 .
   PubMed Web of Science ®Google Scholar
• Singh , B N , Shankar , S and Srivastava , R K . 2011 . Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications . Biochem Pharmacol , 82 : 1807 – 1821 .
   PubMed Web of Science ®Google Scholar
• Dong , Z , Ma , W , Huang , C and Yang , C S . 1997 . Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols (−)-epigallocatechin gallate, and theaflavins . Cancer Res. , 57 : 4414 – 4419 .
   PubMed Web of Science ®Google Scholar
• Lu , G , Liao , J , Yang , G , Reuhl , K R , Hao , X and Yang , C S . 2006 . Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced lung tumorigenesis model in a/j mice by tea polyphenols and caffeine . Cancer Res. , 66 : 11494 – 11501 .
   PubMed Web of Science ®Google Scholar
• Chung , J Y , Huang , C , Meng , X , Dong , Z and Yang , C S . 1999 . Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in h-ras-transformed cells: structure-activity relationship and mechanisms involved . Cancer Res. , 59 : 4610 – 4617 .
   PubMed Web of Science ®Google Scholar
• Liang , Y C , Lin Shiau , S Y , Chen , C F and Lin , J K . 1999 . Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)-epigallocatechin-3-gallate . J Cell Biochem. , 75 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Katiyar , S K , Afaq , F , Perez , A and Mukhtar , H . 2001 . Green tea polyphenol (−)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress . Carcinogen. , 22 : 287 – 294 .
   PubMed Web of Science ®Google Scholar
• Deguchi , H , Fujii , T , Nakagawa , S , Koga , T and Shirouzu , K . 2002 . Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D . Int J Oncol. , 21 : 1301 – 1305 .
   PubMed Web of Science ®Google Scholar
• Maeda-Yamamoto , M , Suzuki , N , Sawai , Y , Miyase , T , Sano , M , Hashimoto-Ohta , A and Isemura , M . 2003 . Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells . J Agric Food Chem. , 51 : 1858 – 1863 .
   PubMed Web of Science ®Google Scholar
• Kuhn , DJ , Burns , A C , Kazi , A and Dou , Q P . 2004 . Direct inhibition of the ubiquitinproteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor . Biochim Biophys Acta , 1682 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Kim , HS , Kim , M H , Jeong , M , Hwang , Y S , Lim , S H , Shin , B A , Ahn , BW and Jung , Y D . 2004 . EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells . Anticancer Res , 24 : 747 – 753 .
   PubMed Web of Science ®Google Scholar
• Manna , S , Mukherjee , S , Roy , A , Das , S and Panda , C K . 2009 . Tea polyphenols can restrict benzo[a]pyrene-induced lung carcinogenesis by altered expression of p53-associated genes and H-ras, c-myc and cyclin D1 . J Nutr Biochem , 20 : 337 – 349 .
   PubMed Web of Science ®Google Scholar
• Harakeh , S , Abu-El-Ardat , K , Diab-Assaf , M , Niedzwiecki , A , El-Sabban , M and Rath , M . 2008 . Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and negative leukemia cells . Med Oncol , 25 : 30 – 39 .
   PubMedGoogle Scholar
• Thakur , VS , Gupta , K and Gupta , S . 2012 . Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases . Carcinogen , 33 ( 2 ) : 377 – 384 .
   PubMed Web of Science ®Google Scholar
• Masuda , M , Suzui , M and Weinstein , I B . 2001 . Effects of epigallocatechin- 3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines . Clin Cancer Res. , 7 : 4220 – 4229 .
   PubMed Web of Science ®Google Scholar
• Masuda , M , Suzui , M , Lim , J T , Deguchi , A , Soh , J W and Weinstein , I B . 2002 . Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction . J Exp Ther Oncol , 2 : 350 – 359 .
   PubMedGoogle Scholar
• Shimizu , M , Deguchi , A , Lim , J T , Moriwaki , H , Kopelovich , L and Weinstein , I B . 2005 . (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells . Clin Cancer Res , 11 ( 7 ) : 2735 – 2746 .
   PubMed Web of Science ®Google Scholar
• Hoffmann , J , Junker , H , Schmieder , A , Venz , S , Brandt , R , Multhoff , G , Falk , W and Radons , J . 2011 . EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells . Biochem Pharmacol , 82 : 1153 – 1162 .
   PubMed Web of Science ®Google Scholar
• Shi , ST , Wang , Z Y , Smith , T J , Hong , J Y , Chen , W F , Ho , C T and Yang , C S . 1994 . Effects of green leaf and black tea on 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone bioactivation, DNA methylation. and lung tumorigenesis in A/J mice . Cancer Res. , 54 : 4641 – 4647 .
   PubMed Web of Science ®Google Scholar
• Chung , FL , Wang , M , Rivenson , A , Iatropoulos , M J , Reinhardt , J C , Pittman , B , Ho , C T and Amin , S G . 1998 . Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent . Cancer Res , 58 : 4096 – 4101 .
   PubMed Web of Science ®Google Scholar
• Kumar , G , Dange , P , Kailaje , V , Vaidya , M M , Ramchandani , A G and Maru , G B . 2012 . Polymeric black tea polyphenols modulate the localization and activity of 12-O-tetradecanoylphorbol-13-acetate-mediated kinases in mouse skin: mechanisms of their anti-tumor-promoting action . Free Radic Biol Med , 53 ( 6 ) : 1358 – 1370 .
   PubMedGoogle Scholar
• Mujtaba , T and Dou , Q P . 2012 . Black tea polyphenols inhibit tumor proteasome activity . In Vivo , 26 ( 2 ) : 197 – 202 .
   PubMed Web of Science ®Google Scholar
• Bachmeier , B , Nerlich , A G , Iancu , C M , Cilli , M , Schleicher , E , Vené , R , Dell’Eva , R , Jochum , M , Albini , A and Pfeffer , U . 2007 . The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice . Cell Physiol Biochem. , 19 : 137 – 152 .
   PubMed Web of Science ®Google Scholar
• Chen , H W , Yu , S L , Chen , J J , Li , H N , Lin , Y C Yao , P L . 2004 . Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis . Mol Pharmacol. , 65 : 99 – 110 .
   PubMed Web of Science ®Google Scholar
• Chen , H W , Lee , J Y , Huang , J Y , Wang , C C , Chen , W J Su , S F . 2008 . Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1 . Cancer Res. , 68 : 7428 – 7438 .
   PubMed Web of Science ®Google Scholar
• Cai , XZ , Wang , J , Li , XD , Wang , GL , Liu , FN , Cheng , MS and Li , F . 2009 . Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression . Cancer Biol Ther. , 8 : 1360 – 1368 .
   PubMed Web of Science ®Google Scholar
• Rao , CV , Rivenson , A , Simi , B and Reddy , B S . 1995 . Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound . Cancer Res. , 55 : 259 – 266 .
   PubMed Web of Science ®Google Scholar
• Kawamori , T , Lubet , R , Steele , VE , Kelloff , GJ , Kaskey , RB , Rao , CV and Reddy , B S . 1999 . Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer . Cancer Res , 59 : 597 – 601 .
   PubMed Web of Science ®Google Scholar
• Goel , A and Aggarwal , B B . 2010 . Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs . Nutr Cancer. , 62 : 919 – 930 .
   PubMed Web of Science ®Google Scholar
• Han , SS , Keum , YS , Seo , HJ and Surh , Y J . 2002 . Curcumin suppresses activation of NFkappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells . J Biochem Mol Biol. , 35 : 337 – 342 .
   PubMedGoogle Scholar
• Kang , G , Kong , PJ , Yuh , YJ , Lim , SY , Yim , SV , Chun , W and Kim , S S . 2004 . Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells . J Pharmacol Sci. , 94 : 325 – 328 .
   PubMed Web of Science ®Google Scholar
• Liu , JY , Lin , SJ and Lin , J K . 1993 . Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells . Carcinogen. , 14 : 857 – 861 .
   PubMed Web of Science ®Google Scholar
• Mohan , R , Sivak , J , Ashton , P , Russo , LA , Pham , BQ , Kasahara , N , Raizman , MB and Fini , M E . 2000 . Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B . J Biol Chem. , 275 : 10405 – 10412 .
   PubMed Web of Science ®Google Scholar
• Korutla , L and Kumar , R . 1994 . Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells . Biochim Biophys Acta. , 1224 : 597 – 600 .
   PubMed Web of Science ®Google Scholar
• Korutla , L , Cheung , JY , Mendelsohn , J and Kumar , R . 1995 . Inhibition of ligand induced activation of epidermal growth factor receptor tyrosine phosphotylation by curcumin . Carcinogen. , 16 : 1741 – 1745 .
   PubMed Web of Science ®Google Scholar
• Kaneuchi , M , Sasaki , M , Tanaka , Y , Yamamoto , R , Sakuragi , N and Dahiya , R . 2003 . Resveratrol suppresses growth of Ishikawa cells through down regulation of EGF . Int J Oncol. , 23 : 1167 – 1172 .
   PubMed Web of Science ®Google Scholar
• Prasad , CP , Rath , G , Mathur , S , Bhatnagar , D and Ralhan , R . 2010 . Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines . Chem Biol Interact. , 183 : 455 – 461 .
   PubMedGoogle Scholar
• Shao , Z M , Shen , Z Z , Liu , C H , Sartippour , M R , Go , V L , Heber , D and Nguyen , M . 2002 . Curcumin exerts multiple suppressive effects on human breast carcinoma cells . Int J Cancer. , 98 : 234 – 240 .
   PubMed Web of Science ®Google Scholar
• Su , C C , Chen , G W , Lin , J G , Wu , L T and Chung , J G . 2006 . Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions . Anticancer Res. , 26 : 1281 – 1288 .
   PubMed Web of Science ®Google Scholar
• Leow , P C , Tian , Q , Ong , Z Y , Yang , Z and Ee , P L . 2010 . Antitumor activity of natural compounds, curcumin and PKF118–310, as Wnt/beta-catenin antagonists against human osteosarcoma cells . Invest New Drugs. , 28 : 766 – 782 .
   PubMedGoogle Scholar
• Ohashi , Y , Tsuchiya , Y , Koizumi , K , Sakurai , H and Saiki , I . 2003 . Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model . Oncology. , 65 : 250 – 258 .
   PubMedGoogle Scholar
• Singh , M and Singh , N . 2011 . Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells . Mol Cell Biochem. , 347 : 1 – 11 .
   PubMed Web of Science ®Google Scholar
• Madden , K , Flowers , L , Salani , R , Horowitz , I , Logan , S , Kowalski , K , Xie , J and Mohammed , S I . 2009 . Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer . Prostaglandins Leukot Essent Fatty Acids. , 80 : 9 – 18 .
   PubMed Web of Science ®Google Scholar
• Maher , D M , Bell , M C , O’Donnell , E A , Gupta , B K , Jaggi , M and Chauhan , S C . 2011 . Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7 . Mol Carcinog , 50 : 47 – 57 .
   PubMed Web of Science ®Google Scholar
• Cucciolla , V , Borriello , A , Oliva , A , Galletti , P , Zappia , V and Della Ragione , F . 2007 . Resveratrol: from basic science to the clinic . Cell Cycle. , 6 : 2495 – 2510 .
   PubMed Web of Science ®Google Scholar
• Jang , M , Cai , L , Udeani , G O , Slowing , K V , Thomas , C F Beecher , C W . 1997 . Cancer chemopreventive activity of resveratrol, a natural product derived from grapes . Science , 275 : 218 – 220 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B , Bhardwaj , A , Aggarwal , R S , Seeram , N P , Shishodia , S and Takada , Y . 2004 . Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies . Anticancer Res. , 24 : 2783 – 2840 .
   PubMed Web of Science ®Google Scholar
• Li , H , Xia , N and Förstermann , U . 2012 . Cardiovascular effects and molecular targets of resveratrol . Nitric Oxide. , 26 : 102 – 110 .
   PubMed Web of Science ®Google Scholar
• Leonard , S S , Xia , C , Jiang , B H , Stinefelt , B , Klandorf , H , Harris , G K and Shi , X . 2003 . Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses . Biochem Biophys Res Commun. , 309 : 1017 – 1026 .
   PubMed Web of Science ®Google Scholar
• Woo , J H , Lim , J H , Kim , Y H , Suh , S I , Min , D S , Chang , J S , Lee , Y H , Park , J W and Kwon , T K . 2004 . Resveratrol inhibits phorbol myristate acetateinduced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction . Oncogene. , 23 : 1845 – 1853 .
   PubMed Web of Science ®Google Scholar
• Ulrich , S , Loitsch , S M , Rau , O , von Knethen , A , Brüne , B , Schubert-Zsilavecz , M and Stein , J M . 2006 . Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism . Cancer Res. , 66 : 7348 – 7354 .
   PubMed Web of Science ®Google Scholar
• Zoberi , I , Bradbury , C M , Curry , H A , Bisht , K S , Goswami , P C , Roti Roti , J L and Gius , D . 2002 . Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines . Cancer Lett. , 175 : 165 – 173 .
   PubMed Web of Science ®Google Scholar
• Kramer , M P and Wesierska-Gadek , J . 2009 . Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose . Ann N Y Acad Sci. , 1171 : 257 – 263 .
   PubMedGoogle Scholar
• Guo , W , Nie , L , Wu , D , Wise , M L , Collins , F W , Meydani , S N and Meydani , M . 2010 . Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro . Nutr Cancer. , 62 ( 8 ) : 1007 – 1016 .
   PubMed Web of Science ®Google Scholar
• García-Villalba , R , Carrasco-Pancorbo , A , Oliveras-Ferraros , C , Menéndez , J A , Segura-Carretero , A and Fernández-Gutiérrez , A . 2012 . Uptake and metabolism of olive oil polyphenols in human breast cancer cells using nano-liquid chromatography coupled to electrospray ionization-time of flight-mass spectrometry . J Chromatogr B Analyt Technol Biomed Life Sci , 898 : 69 – 77 .
   PubMedGoogle Scholar
• Defagó , M D and Soria , E A . 2010 . Biomarker assessment in nutritional modulation of oxidative stress-induced cancer development by lipid-related bioactive molecules . Recent Patents on Anti-Cancer Drug Discovery , 5 : 188 – 196 .
   PubMedGoogle Scholar
• Mamede , A C , Tavares , S D , Abrantes , A M , Trindade , J , Maia , J M and Botelho , M F . 2011 . The role of vitamins in cancer: a review . Nutr Cancer , 63 : 479 – 494 .
   PubMed Web of Science ®Google Scholar
• Hill , M J . 1999 . Mechanisms of diet and colon carcinogenesis . Eur J Cancer Prev. , 8 : S95 – S98 .
   PubMedGoogle Scholar
• Borek , C . 2004 . Dietary antioxidants and human cancer . Integr Cancer Ther. , 3 : 333 – 341 .
   PubMedGoogle Scholar
• Briviba , K , Schnäbele , K , Schwertle , E , Blockhaus , M and Rechkemmer , G . 2001 . Beta-carotene inhibits growth of human colon carcinoma cells in vitro by induction of apoptosis . Biol Chem. , 382 : 1663 – 1668 .
   PubMedGoogle Scholar
• Herszényi , L , Farinati , F , Miheller , P and Tulassay , Z . 2008 . Chemoprevention of colorectal cancer: feasibility in everyday practice? . Eur J Cancer Prev. , 17 : 502 – 514 .
   PubMed Web of Science ®Google Scholar
• Williams , C D , Satia , J A , Adair , L S , Stevens , J , Galanko , J , Keku , T O and Sandler , R S . 2010 . Antioxidant and DNA methylation-related nutrients and risk of distal colorectal cancer . Cancer Causes and Control , 21 : 1171 – 1181 .
   PubMed Web of Science ®Google Scholar
• Yeon , J Y , Suh , Y J , Kim , S W , Baik , H W , Sung , C J , Kim , H S and Sung , M K . 2011 . Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk . Nutrition. , 27 : 912 – 918 .
   PubMed Web of Science ®Google Scholar
• Yang , C S , Lu , G , Ju , J and Li , G X . 2010 . Inhibition of inflammation and carcinogenesis in the lung and colon by tocopherols . Ann N Y Acad Sci. , 1203 : 29 – 34 .
   PubMed Web of Science ®Google Scholar
• Kopparapu , N . 2011 . Miracle nutrient . Inter J Phar and Tech , 3 : 1140 – 1164 .
   Google Scholar
• Rath , M and Pauling , L . 1992 . Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic lysine analogs . J Ortho Med. , 7 : 17 – 23 .
   Google Scholar
• Roomi , M W , Ivanov , V , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2004 . Synergistic effect of combination of lysine, proline, arginine, ascorbic acid and epigallocathechin gallate on colon cancer cell line HT116 . J Am Nutrac Assoc. , 7 : 40 – 43 .
   Google Scholar
• Roomi , M W , Ivanov , V , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2005 . In vivo antitumor effect of ascorbic acid, lysine, praline, and green tea extract on human prostate cancer PC-3 xenographs in nude mice: evaluation of tumor growth and immunohistochemistry . In Vivo. , 19 : 179 – 184 .
   PubMed Web of Science ®Google Scholar
• Roomi , M W , Roomi , N W , Ivanov , V , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2005 . Modulation of N-methyl-N-nitrosourea induced mammary tumors in Spargue-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract . Breast Cancer Res. , 7 : R291 – R295 .
   PubMed Web of Science ®Google Scholar
• Roomi , M W , Ivanov , V , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2005 . In vivo antitumor effect of ascorbic acid, lusine, praline and green tea extract on human colon cancer cell HTC 116 xenographs in nude mice . Oncol Rep. , 12 : 421 – 425 .
   Google Scholar
• Roomi , M W , Ivanov , V , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2005 . Antitumor effect of nutrient synergy on human osteosarcoma cells U2OS, MMNG-HOS, and Ewing's sarcoma SK-ES.1 . Oncol Rep. , 13 : 253 – 257 .
   PubMed Web of Science ®Google Scholar
• Harakeh , S , Abdel-Massih , R M , Gil , P R , Sperling , R A , Meinhardt , A , Niedwiecki , A , Rath , M , Parak , W J and Baydoun , E . 2010 . The effect of PEG-coated gold nanoparticles on the anti-proliferative potential of Specific Nutrient Synergy . Nanotoxicology. , 4 ( 2 ) : 177 – 185 .
   PubMed Web of Science ®Google Scholar
• Roomi , M W , Ivanov , V , Kalinovsky , T and Niedzwiecki , A . 2004 . Rath M. Antitumor effect of ascorbic acid, lysine, proline, arginine and epigallocatechin gallate in prostate cancer cell lines PC3, LNCaP and DU 145 . Res Commun Mol Pathol Pharmacol , 115–116 : 251 – 264 .
   PubMedGoogle Scholar
• Niedzwiecki , A , Roomi , M W , Kalinovsky , T and Rath , M . 2010 . Micronutrient synergy- a new tool in effective control of metastasis and other key mechanisms of cancer . Cancer Metastasis Rev , 29 ( 3 ) : 529 – 542 .
   PubMedGoogle Scholar
• Harakeh , S , Diab-Assaf , M , Niedzwiecki , A , Khalife , J , Abu-El-Ardat , K and Rath , M . 2006 . Apoptosis induction by Epican Forte in HTLV-1 positive and negative malignant T-cells . Leuk Res. , 30 : 869 – 881 .
   PubMed Web of Science ®Google Scholar
• Roomi , M W , Ivanov , V , Netke , S , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2006 . In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058 . In Vivo. , 20 ( 1 ) : 25 – 32 .
   PubMedGoogle Scholar
• Roomi , M W , Roomi , N W , Kalinovsky , T , Niedzwiecki , A and Rath , M . 2010 . In vivo and in vitro effect of a nutrient mixture on human hepatocarcinoma cell line SK-HEP-1 . Exp Oncol. , 32 ( 2 ) : 84 – 91 .
   PubMedGoogle Scholar
• Mukhtar , H and Ahmad , N . 1999 . Cancer chemoprevention: future holds in multiple agents: Contemporary issues in Toxicology . Toxicol Appl Pharmacol. , 158 : 207 – 210 .
   PubMed Web of Science ®Google Scholar
• Halliwell , B . 2007 . Dietary polyphenols: good, bad, or indifferent for your health? . Cardiovas Res. , 73 : 341 – 347 .
   PubMed Web of Science ®Google Scholar
• Chen , L , Lee , M J , Li , H and Yang , C S . 1997 . Absorption, distribution, elimination of tea polyphenols in rats . Drug Metab Dispos. , 25 : 1045 – 1050 .
   PubMed Web of Science ®Google Scholar
• Isbrucker , R A , Edwards , J A , Wolz , E , Davidovich , A and Bausch , J . 2005 . Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies . Food Chem Toxicol. , 44 : 636 – 650 .
   Google Scholar
• Bonkovsky , H L . 2006 . Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis) . Ann Intern Med. , 144 : 68 – 71 .
   PubMed Web of Science ®Google Scholar
• Galati , G , Lin , A , Sultan , A M and O’Brien , P J . 2006 . Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins . Free Radical Biol Med. , 40 : 570 – 580 .
   PubMed Web of Science ®Google Scholar
• Lambert , J D , Sang , S and Yang , C S . 2007 . Possible controversy over dietary polyphenols: benefits vs risks . Chem Res Toxicol , 20 : 583 – 585 .
   PubMed Web of Science ®Google Scholar
• Martin , K R and Appel , C L . 2010 . Polyphenols as dietary supplements: a double-edged sword . Nutr Diet Suppl. , 2 : 1 – 12 .
   Google Scholar
• Weisburg , J H , Weissman , D B , Sedaghat , T and Babich , H . 2004 . In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity . Basic Clin Pharmacol Toxicol. , 95 : 191 – 200 .
   PubMed Web of Science ®Google Scholar
• Hong , J , Lu , H , Meng , X , Ryu , J H , Hara , Y and Yang , C S . 2002 . Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells . Cancer Res. , 62 : 7241 – 7246 .
   PubMed Web of Science ®Google Scholar
• Gleiter , H . 2000 . Nanostructured materials: basic concepts and microstructure . Acta Mater , 48 : 1 – 29 .
   Web of Science ®Google Scholar
• McNeil , S E . 2005 . Nanotechnology for the biologist . J Leuko Biol. , 78 : 585 – 594 .
   PubMed Web of Science ®Google Scholar
• Grodzinski , P , Silver , M and Molnar , L K . 2006 . Nanotechnology for cancer diagnostics: promises and challenges . Expert Rev Mol Diagn. , 6 ( 3 ) : 307 – 318 .
   PubMed Web of Science ®Google Scholar
• Devalapally , H , Shenoy , D , Little , S , Langer , R and Amiji , M . 2007 . Poly (ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model . Cancer Chemo Pharmacol. , 59 ( 4 ) : 477 – 484 .
   PubMed Web of Science ®Google Scholar
• Kawasaki , E S and Player , A . 2005 . Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer . Nanomedicine , 1 : 101 – 109 .
   PubMed Web of Science ®Google Scholar
• Ferrari , M . 2005 . Cancer nanotechnology: opportunities and challenges . Nat Rev Cancer , 5 : 161 – 171 .
   PubMed Web of Science ®Google Scholar
• Alexis , F , Pridgen , E , Molnar , L K and Farokhzad , O C . 2008 . Factors affecting the clearance and biodistribution of polymeric nanoparticles . Mol Pharm , 5 : 505 – 515 .
   PubMed Web of Science ®Google Scholar
• Jain , R K . 1987 . Transport of molecules in the tumor interstitium: a review . Cancer Res , 47 : 3039 – 3051 .
   PubMed Web of Science ®Google Scholar
• Davis , M E , Chen , Z G and Shin , D M . 2008 . Nanoparticle therapeutics: an emerging treatment modality for cancer . Nat Rev Drug Discov. , 7 : 771 – 782 .
   PubMed Web of Science ®Google Scholar
• Nair , H B , Sung , B , Yadav , V R , Kannappan , R , Chaturvedi , M M and Aggarwal , B B . 2010 . Delivery of anti-inflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer . Biochem Pharmacol. , 80 ( 12 ) : 1833 – 1843 .
   PubMed Web of Science ®Google Scholar
• Duncan , R , Vicent , M J , Greco , F and Nicholson , R I . 2005 . Polymer-drug conjugates: towards a novel approach for the treatment of endocrine-related cancer . Endocr Relat Cancer. , 12 ( Suppl 1 ) : S189 – 199 .
   PubMedGoogle Scholar
• Vaupel , P , Kallinowski , F and Okunieff , P . 1989 . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review . Cancer Res. , 49 : 6449 – 6465 .
   PubMed Web of Science ®Google Scholar
• Schellenberger , E A , Bogdanov , A Jr. , Hogemann , D , Tait , J , Weissleder , R and Josephson , L . 2002 . Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol Imaging . 1 : 102 – 107 .
   Google Scholar
• Mazar , A P . 2008 . Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy . Clin Cancer Res , 14 : 5649 – 5655 .
   PubMed Web of Science ®Google Scholar
• Ganta , S and Amiji , M . 2009 . Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells . Mol Pharm , 6 : 928 – 939 .
   PubMed Web of Science ®Google Scholar
• Szoka , F Jr. and Papahadjopoulos , D . 1978 . Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation . Proc Natl Acad Sci U S A , 75 : 4194 – 4198 .
   PubMed Web of Science ®Google Scholar
• Kim , S and Martin , G M . 1981 . Preparation of cell-size unilamellar liposomes with high captured volume and defined size distribution . Biochim Biophys Acta , 646 : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Meure , L A , Foster , N R and Dehghani , F . 2008 . Conventional and dense gas techniques for the production of liposomes: a review . AAPS PharmSciTech , 9 : 798 – 809 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Adhami , V M , Ahmad , N and Mukhtar , H . 2010 . Nanochemoprevention: sustained release of bioactive food components for cancer prevention . Nutr Cancer. , 62 ( 7 ) : 883 – 890 .
   PubMed Web of Science ®Google Scholar
• Gref , R , Minamitake , Y , Peracchia , M T , Trubetskoy , V , Torchilin , V and Langer , R . 1994 . Biodegradable long circulating polymeric nanospheres . Science. , 263 : 1600 – 1603 .
   PubMed Web of Science ®Google Scholar
• Peer , D , Karp , J M , Hong , S , Farokhzad , O C , Margalit , R and Langer , R . 2007 . Nanocarriers as an emerging platform for cancer therapy . Nat Nanotechnol. , 2 : 751 – 760 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Adhami , V M , Christopher , J , Chamcheu and Mukhtar , H . 2012 . Impact of nanotechnology in cancer: emphasis on nanochemoprevention . Int J Nanomed. , 7 : 591 – 605 .
   PubMed Web of Science ®Google Scholar
• Anand , P , Nair , H B , Sung , B , Kunnumakkara , AB , Yadav , VR Tekmal , RR . 2010 . Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo . Biochem Pharmacol. , 79 ( 3 ) : 330 – 338 .
   PubMed Web of Science ®Google Scholar
• Sharma , R A , McLelland , H R , Hill , K A , Ireson , C R , Euden , S A Manson , M M . 2001 . Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer . Clin Cancer Res , 7 : 1894 – 1900 .
   PubMed Web of Science ®Google Scholar
• Sharma , R A , Euden , S A , Platton , S L , Cooke , D N , Shafayat , A Hewitt , H R . 2004 . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance . Clin Cancer Res , 10 : 6847 – 6854 .
   PubMed Web of Science ®Google Scholar
• Cruz-Correa , M , Shoskes , D A , Sanchez , P , Zhao , R , Hylind , L M Wexner , S D . 2006 . Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis . Clin Gastroenterol Hepatol , 4 : 1035 – 1038 .
   PubMed Web of Science ®Google Scholar
• Dhillon , N , Aggarwal , B B , Newman , R A , Wolff , R A , Kunnumakkara , A B Abbruzzese , J L . 2008 . Phase II trial of curcumin in patients with advanced pancreatic cancer . Clin Cancer Res , 14 : 4491 – 4499 .
   PubMed Web of Science ®Google Scholar
• Bhardwaj , A , Sethi , G , Vadhan-Raj , S , Bueso-Ramos , C , Takada , Y Gaur , U . 2007 . Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells . Blood , 109 : 2293 – 22302 .
   PubMed Web of Science ®Google Scholar
• Mohanty , C , Das , M and Sahoo , S K . 2012 . Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin . Exp Opin Drug Deliv. , doi:10.1517/17425247.2012.724676
   PubMedGoogle Scholar
• Bisht , S , Feldmann , G , Soni , S , Ravi , R , Karikar , C and Maitra , A . 2007 . Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy . J Nanobiotechnology , 5 : 3
   PubMedGoogle Scholar
• Sahu , A , Kasoju , N and Bora , U . 2008 . Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells . Biomacromolecules , 9 : 2905 – 2912 .
   PubMed Web of Science ®Google Scholar
• Thangapazham , R L , Puri , A , Tele , S , Blumenthal , R and Maheshwari , R K . 2008 . Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells . Int J Oncol. , 32 ( 5 ) : 1119 – 1123 .
   PubMed Web of Science ®Google Scholar
• Das , R K , Kasoju , N and Bora , U . 2010 . Encapsulation of curcumin in alginatechitosan-pluronic composite nanoparticles for delivery to cancer cells . Nanomedicine. , 6 ( 1 ) : 153 – 160 .
   PubMed Web of Science ®Google Scholar
• Li , J , Wang , Y , Yang , C , Wang , P , Delschlager , DK Zheng , Y . 2009 . Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1 . Mol Pharmacol. , 76 ( 1 ) : 81 – 90 .
   PubMed Web of Science ®Google Scholar
• Anand , P , Nair , H B , Sung , B , Kunnumakkara , AB , Yadav , VR Tekmal , RR . 2010 . Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo . Biochem Pharmacol , 79 : 330 – 338 .
   PubMed Web of Science ®Google Scholar
• Onoue , S , Takahashi , H , Kawabata , Y , Seto , Y , Hatanaka , J Timmermann , B . 2010 . Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability . J Pharm Sci. , 99 ( 4 ) : 1871 – 1881 .
   PubMed Web of Science ®Google Scholar
• Sou , K , Oyajobi , B , Goins , B , Phillips , W T and Tsuchida , E . 2009 . Characterization and cytotoxicity of self-organized assemblies of curcumin and amphipathic poly(ethylene glycol) . J Biomed Nanotechnol. , 5 ( 2 ) : 202 – 208 .
   PubMedGoogle Scholar
• Yallapu , M M , Gupta , B K , Jaggi , M and Chauhan , S C . 2010 . Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells . J Colloid Interface Sci. , 351 ( 1 ) : 19 – 29 .
   PubMed Web of Science ®Google Scholar
• Shaikh , J , Ankola , D D , Beniwal , V , Singh , D and Ravi Kumar , M NV . 2009 . Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer . Eur J Pharm Sci. , 37 : 223 – 230 .
   PubMed Web of Science ®Google Scholar
• Zhou , X J , Hu , X M , Yi , Y M and Wan , J . 2009 . Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles . Drug Dev Ind Pharm , 35 : 305 – 310 .
   PubMed Web of Science ®Google Scholar
• Barras , A , Mezzetti , A , Richard , A , Lazzaroni , S , Roux , S Melnyk , P . 2009 . Formulation and characterization of polyphenol-loaded lipid nanocapsules . Int J Pharm , 379 : 270 – 277 .
   PubMed Web of Science ®Google Scholar
• Barik , A , Priyadarsini , K I and Mohan , H . 2003 . Photophysical studies on binding of curcumin to bovine serum albumins . Photochem Photobiol , 77 : 597 – 603 .
   PubMed Web of Science ®Google Scholar
• Shutava , T G , Balkundi , S S , Vangala , P , Steffan , J J , Bigelow , R L , Cardelli , J A , O’Neal , D P and Lvov , Y M . 2009 . Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols . ACS Nano , 3 ( 7 ) : 1877 – 1885 .
   PubMed Web of Science ®Google Scholar
• Italia , J L , Datta , P , Ankola , D D and Kumar , MNVR . 2008 . Nanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution . J Biomed Nanotechnol , 4 : 304 – 312 .
   Web of Science ®Google Scholar
• Siddiqui , I A , Adhami , V M , Bharali , D J , Hafeez , BB , Asim , M Khwaja , SI . 2009 . Introducing nanochemo-prevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate . Cancer Res , 69 : 1712 – 1716 .
   PubMed Web of Science ®Google Scholar
• Hu , B , Ting , Y , Yang , X , Tang , W , Zeng , X and Huang , Q . 2012 . Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability . Chem Commun. , 48 : 2421 – 2423 .
   PubMed Web of Science ®Google Scholar
• Rocha , S , Generalov , R , Pereira Mdo , C , Peres , I , Juzenas , P and Coelho , M A . 2011 . Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention . Nanomedicine (Lond) , 6 ( 1 ) : 79 – 87 .
   PubMed Web of Science ®Google Scholar
• Singh , M , Bhatnagar , P , Srivastava , A K , Kumar , P , Shukla , Y and Gupta , K C . 2011 . Enhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticles . J Biomed Nanotechnol. , 7 ( 1 ) : 202
   PubMed Web of Science ®Google Scholar
• Narayanan , N K , Nargi , D , Randolph , C and Narayanan , B A . 2009 . Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice . Int J Cancer. , 125 ( 1 ) : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Teskac , K and Kristl , J . 2010 . The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol . Int J Pharm. , 390 ( 1 ) : 61 – 69 .
   PubMed Web of Science ®Google Scholar
• Wang , D , Taylor , E W , Wang , Y , Wan , X and Zhang , J . 2012 . Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention . Int J Nanomedicine , 7 : 1711 – 1721 .
   PubMed Web of Science ®Google Scholar
• Hsieh , D S , Wang , H , Tan , S W , Huang , YH , Tsai , CY Yeh , MK . 2011 . The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles . Biomaterials. , 32 ( 30 ) : 7633 – 7640 .
   PubMed Web of Science ®Google Scholar
• Jeong , S Y , Park , S J , Yoon , S M , Jung , J , Woo , H N Yi , S L . 2009 . Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization . J Control Release , 139 : 239 – 245 .
   PubMed Web of Science ®Google Scholar
• Blanco , E , Bey , E A , Dong , Y , Weinberg , B D , Sutton , D M Boothman , D A . 2007 . Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells . J Control Release , 122 : 365 – 374 .
   PubMed Web of Science ®Google Scholar
• Mukerjee , A and Vishwanatha , J K . 2009 . Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy . Anticancer Res , 29 : 3867 – 3875 .
   PubMed Web of Science ®Google Scholar
• Gupta , V , Aseh , A , Rios , C N , Aggarwal , B B and Mathur , A B . 2009 . Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy . Int J Nanomedicine , 4 : 115 – 122 .
   PubMed Web of Science ®Google Scholar
• Zu , Y G , Yuan , S , Zhao , X H , Zhang , Y , Zhang , X N and Jiang , R . 2009 . Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles . Yao Xue Xue Bao , 44 : 525 – 531 .
   PubMedGoogle Scholar